Product Images Pregabalin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 14 images provide visual information about the product associated with Pregabalin NDC 80425-0277 by Advanced Rx Pharmacy Of Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Description - Description

Description - Description

label 1 - Pregabalin 80425 0277 03

label 1 - Pregabalin 80425 0277 03

This is a package of 90 capsules containing 100mg of Pregabalin, with a comparison to a similar drug called Lyrica. It includes a product code and source number, as well as an expiration date of 12/31/2025. The name of the company that packaged it is Advancedix.*

fig 1 - fig 1

fig 1 - fig 1

fig 10 - fig 10

fig 10 - fig 10

This appears to be a table showing the estimated percentage of subjects without LTR (possibly a medical term or abbreviation) for a medication called Progabain compared to a placebo over a period of 120 to 180 days. The percentages range from 0% to 100%, with increments of 10%.*

fig 11 - fig 11

fig 11 - fig 11

fig 12 - fig 12

fig 12 - fig 12

The text shows a chart displaying the percentages of subjects who improved while taking Pregabalin and placebo medication over a course of 16 weeks. The data is presented using a numbered scale from 210 to 280 and shows that 100% of the subjects improved while taking Pregabalin. There is not enough information to provide a more detailed description.*

fig 2 - fig 2

fig 2 - fig 2

The text describes a chart or table showing the percent of patients improved with Pregabalin 160 mg within 3 days and percent improvement in pain from baseline. There are some numerical values indicated in the table such as 100, 2, 10, 220, 23, 20, 280, 2 and 23w. However, as the content is incomplete, it is difficult to derive any more information.*

fig 3 - fig 3

fig 3 - fig 3

This text appears to be a mix of numerical data and medication names, with some missing characters making it difficult to interpret accurately. Given the lack of context or further information, it is not possible to generate a useful description.*

fig 4 - fig 4

fig 4 - fig 4

fig 5 - fig 5

fig 5 - fig 5

This appears to be a chart or table showing the performance of different medications in a study. The medications listed are Fregabalin, Pregataiin, and Placebo. The dosages are also given for each medication. The chart shows that 38 patients improved, but it is not clear what they improved from or how many total patients were in the study. The last row appears to show the percent improvement in pain from baseline, but the format is difficult to interpret without more information.*

fig 6 - fig 6

fig 6 - fig 6

This document does not provide enough information for a useful description.*

fig 7 - fig 7

fig 7 - fig 7

fig 9 - fig 9

fig 9 - fig 9

The text represents a graph showing the percentage of patients improved in terms of pain, comparing the effects of Pregabalin at different daily doses and a placebo. The percentage of improvement in pain from baseline ranges from 20 to 80 percent, while the doses of Pregabalin are 300mg and 450mg daily.*

formula - formula

formula - formula

This text appears to be a formula for calculating creatinine clearance (CLCT) using the patient's age, weight, and serum creatinine level. It is unclear what the "mmmmmmm" and "e e" parts represent, but the formula notes that a multiplication factor of 0.85 should be applied for female patients.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.